Online Education

How Does Blood Clot?

The purpose of this activity is to enable the learner to improve understanding of and increase interest in the basic concepts involved in the complex coagulation process to ultimately improve patient care.

• Examine the coagulation process from the point of injury to clot resolution.
• Evaluate the platelet reaction step of normal hemostasis.
• Differentiate among the three coagulation pathways, including the various clotting factors that participate in hemostasis.

Nurses and other healthcare staff employed within or affiliated with the U.S. Hemophilia Treatment Center (HTC) network.

An animated module illustrating the coagulation cascade.

• Roshni Kulkarni, MD
• Usha M. Reddy, MD
• Bruce L. Evatt, MD

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

Hemophilia in Pictures

The purpose of Hemophilia in Pictures is to provide basic knowledge about hemophilia through pictures and easy-to-understand information.

Hemophilia in Pictures has many goals. Please refer to the HIP Educators Guide to learn more about the educational goals for Educators as well as People with Hemophilia.

Hemophilia in Pictures is for hemophilia educators and people with hemophilia alike. The information is basic and is provided through pictures and easy-to-understand language, so it is accessible to anyone.

This online learning module covers a range of topics, including an introduction to hemophilia, assessing and managing bleeds, treatment of bleeds, staying healthy and preventing bleeds, and venipuncture and home therapy.

• Lara Oyesiku, Chair of the HIP Working Group and Nurse's Committee, England
• Martin Bedford, Educational Advisor, England
• Annie Gillham, Nurse Advisor, South Africa
• Dr. Peter Jones, Medical Advisor, England
• Kathy Mulder, Physiotherapy Advisor, Canada
• David Page, Educational Advisor, Canada
• Laurie Blackstock, WFH Education Officer

2005

Upon launching the presentation, there are three handouts available for you to print or save for future reference: Educator Guide, Educator Glossary, and On Screen Notes.
To access the handouts, click on the paperclip icon located in the lower right portion of the presentation box.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

The Role of the Nurse in Hemophilia Care

The purpose of this module is to familiarize the learner with the critical role nurses play worldwide in the multidisciplinary care team.

• Examine the critical and variable role of the nurse in the care of people with hemophilia.
• Review the role responsibilities of the nurse related to education, care delivery, coordination of the healthcare team, and support of patient and family to learn to live with hemophilia.

While there are some responsibilities that are universal for all nurses, there is also a great deal of variation in the role and responsibilities of nurses in hemophilia care. This learning module describes those roles and responsibilities and some of the variation that may occur throughout the world.

• World Federation of Hemophilia

June 18, 2013

This module was created to describe the worldwide variation in the role and responsibilities of nurses in hemophilia care.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

18CE044 - Is That OK? Ethical Dilemmas In Our Community

The purpose of this learning activity is to enable the learner to enhance competencies to recognize ethical dilemmas, identify the relevant ethical concepts and principles, and apply the ethical decision-making process to resolve these dilemmas.

• Define ethics and the essential questions underlying ethical theories
• Differentiate ethical theories of conduct and ethical theories of character
• Distinguish four settings in which ethics and ethical action are ongoing considerations
• Interpret key ethical principles and the ethical decision-making process
• Identify relevant ethical principles in common ethical dilemmas encountered by persons with bleeding disorders and their providers

Members of the hemophilia treatment center (HTC) multidisciplinary comprehensive care team including Nurses and Social Workers

This online learning activity provides healthcare professionals and others an opportunity to gain knowledge about ethical theories, key ethical concepts, and the opportunity to apply these theories and concepts through case study examples.

• Kristie Ostash, MD
• Sabrina Farina, LMSW
• Jim Munn, MS, BS, BSN, RN-BC
• Natalie Duncan, MPH

July 31, 2018

5:00 PM Eastern, July 31, 2019

The estimated time to complete this activity is 30 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form.
• Complete the learning activity.
• Complete the evaluation.
• Complete the post-test with a score of 80% or better.
• Upon successful completion of the post-test your certificate of completion will be available to print or save.

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is provided for 0.5 contact hours under ANCC criteria.

This program is Approved by the National Association of Social Workers (Approval # 886604222-9261) for 1 continuing education contact hours.

The Indiana Hemophilia and Thrombosis Center is an approved provider of continuing social work education by the National Association of Social Workers (Provider #886604222).

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

19CE071 - Hydroxyurea for the Treatment of Sickle Cell Disease

The purpose of this activity is to enable the learner to enhance his or her knowledge about the complications of sickle cell disease and the importance of hydroxyurea in reducing or preventing those complications; as well as to gain familiarity with the 2014 NHLBI guidelines concerning hydroxyurea treatment for adults living with sickle cell disease.

• Describe the most common complications of sickle cell disease, including acute chest syndrome, vaso-occlusive pain crisis, and stroke
• Discuss the rationale behind hydroxyurea as a treatment for sickle cell disease and its effectiveness at preventing sickle cell-related complications
• Analyze the mechanism of action, dosing, side effects, contraindications, and monitoring of hydroxyurea therapy for sickle cell disease
• Review the 2014 NHLBI Guidelines for hydroxyurea treatment for persons living with sickle cell disease

Nurses, nurse practitioners, physician assistants, and other health care providers who treat persons with sickle cell disease and wish to improve their knowledge of hydroxyurea as a treatment for sickle cell disease as well as hydroxyurea prescribing practices, with the aim of improving health outcomes among persons with sickle cell disease.

This online educational program reviews the most common complications of sickle cell disease and introduces the most efficacious therapy currently available to treat and prevent these complications, hydroxyurea. The authors discuss the rationale behind hydroxyurea as a therapy, its effectiveness, and national prescribing guidelines.

• Emily Riehm Meier, MD, MSHS

March 19, 2019

5:00 PM, Eastern, March 15, 2020

The estimated time to complete this activity is 45 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better. Successful completion of the post-test is required to earn AAPA Category 1 CME credit. Successful completion is defined as a cumulative score of at least 70 percent correct.
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is provided for 0.75 contact hours under ANCC criteria.

This activity is provided for 0.3 contact hours related to pharmacotherapeutic content.

---

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid for one year from 03/15/2019. PAs should only claim credit commensurate with the extent of their participation.

Contact Information

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

System Requirements

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

18CE053 - Bleeding Disorders Interactive Primer: Women and Hemophilia

The purpose of this online learning activity is to enable the learner to examine the shifting paradigm and emerging developments surrounding symptomatology, diagnostics and management of women with hemophilia.

• Discuss genetic inheritance of hemophilia and the likelihood that offspring will inherit the gene for hemophilia
• Distinguish the types of female carriers including the reasons for proactively identifying and evaluating these individuals
• Investigate bleeding problems and treatment of bleeding in women with hemophilia and symptomatic carriers
• Describe the psychosocial concerns of women with hemophilia and the gaps pertaining to the psychosocial experience of these women
• Recommend appropriate infusion products for women with hemophilia and previously untreated patients (PUPs)
• Relate current methods of prenatal diagnosis of hemophilia
• Discuss potential issues and complications in delivering a neonate with suspected hemophilia

Nurses, nurse practitioners, and other clinical professionals who routinely encounter women with bleeding symptoms and/or wish to learn more about the evolution of thought regarding symptomatic female carriers of hemophilia.

This learning activity explores the pertinent topic of women with hemophilia and symptomatic carriers, including the identification and diagnosis of carriers and management of potential complications in these women and neonates with suspected hemophilia. While hemophilia was historically viewed as a disorder affecting males alone, it is now known that female carriers may have low clotting factor activity levels and experience increased risk of bleeding, even when their factor activity levels are normal. Many of the bleeding symptoms in women are under-recognized and exclusive to females. It is a national clinical and public health priority to increase provider capacity for early identification and appropriate management of women with hemophilia and symptomatic carriers. Because federally recognized U.S. hemophilia treatment centers are likely to see a large proportion of women with hemophilia and symptomatic carriers, it is important for staff at these centers to develop expertise in early identification and proper management of these women. This interactive activity uses case studies with clinical questions for the learner, accompanying patient charts, and a Reading Room with background information to assist with appropriate decision making in the diagnosis and management of women with hemophilia and symptomatic carriers.

• Sarah H. O’Brien, MD, MSc
• Sweta Gupta, MD
• Jennifer Maahs, MSN, PNP, RN-BC

December 28, 2018

5:00 PM, Eastern, December 18, 2019

The estimated time to complete this activity is 60 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better. Successful completion of the post-test is required to earn AAPA Category 1 CME credit. Successful completion is defined as a cumulative score of at least 70 percent correct.
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is provided for 1.0 contact hours under ANCC criteria.

---

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid for one year from 12/18/2018. PAs should only claim credit commensurate with the extent of their participation.

Contact Information

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

System Requirements

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

18CE051 - Bleeding Disorders Interactive Primer: Sports Injuries in Mild Hemophilia

The purpose of this module is to enable the learner to relate to the diagnostics and treatments of sports-related injuries and complications that may occur in persons with mild hemophilia.

• Explain common treatments utilized in management of mild hemophilia
• Identify the primary laboratory test utilized to differentiate mild hemophilia A and Type 2N von Willebrand disease
• Evaluate the use of desmopressin in patients with mild hemophilia, including potential limitations
• Explain the benefits of Rest, Ice, Compression, and Elevation (RICE) when utilized in musculoskeletal bleeding episodes
• Assess the use of physical therapy for managing acute musculoskeletal bleeding episodes in mild hemophilia
• Recommend appropriate sports activities for persons with mild hemophilia
• Review the clinical presentation, management, and potential complications of iliopsoas bleeding in persons with mild hemophilia

This learning activity is targeted toward nursing professionals, physician assistants and other members of the multidisciplinary comprehensive care team in the federally recognized U.S. Hemophilia Treatment Center Network (USHTCN) who treat persons with mild hemophilia. The activity also aims to educate nursing professionals, physician assistants, and other providers in emergency, primary care, joint/orthopedic health and sports medicine settings in which persons with mild hemophilia may present with bleeding complications.

Sports Injuries in Mild Hemophilia is an interactive learning activity that explains the treatment of mild hemophilia, including information about the use of desmopressin and its potential limitations in patients with mild hemophilia A, the role of RICE therapy as an important nonpharmacologic intervention to treat bleeding episodes, and the importance of physical therapy in management and resolution of musculoskeletal bleeding episodes. The activity covers the clinical presentation, medical management, physical therapy, and complications of iliopsoas bleeds, which warrant particular attention given their potential to be life-threatening. The activity also addresses distinction between mild hemophilia A and Type 2N von Willebrand disease, which must be included in the differential diagnosis. Finally, the learning activity discusses selection of appropriate sports activities for persons with bleeding disorders. The learner will be presented with Reading Room material that may be printed or saved for future reference. Two case studies are presented with patient chart information and interactive question-and-answer slides to allow the learner the opportunity to apply what has been learned.

• Sweta Gupta, MD
• Christine Kempton, MD, MSc

June 1, 2018

5:00 PM, Eastern, June 1, 2019

The estimated time to complete this activity is 45 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 80% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is provided for 0.75 contact hours under ANCC criteria.

---

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid for one year from 06/01/2018. PAs should only claim credit commensurate with the extent of their participation.

Contact Information

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

System Requirements

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

19CE070 - Comprehensive Care of Adolescents and Young Adults with Sickle Cell Disease

The purpose of this activity is to enable the learner to gain the knowledge necessary to better manage the comprehensive care of adolescents and young adults with sickle cell disease, with the aim of improving health outcomes among these individuals.

• Interpret the screening tests needed for adolescents and young adults (AYAs) with sickle cell disease
• Identify the most commonly used medications for AYAs with sickle cell disease
• Describe the gaps in knowledge in reproductive issues for patients with sickle cell disease receiving hydroxyurea therapy
• Describe the contraceptive choices in girls and women with sickle cell disease
• Review management of priapism, both ischemic and stuttering
• Discuss practical strategies in pain management for AYAs with sickle cell disease

Nurses, nurse practitioners, physician assistants, and other health care providers who treat persons with sickle cell disease and wish to improve comprehensive care services provided to adolescents and young adults with sickle cell disease

This online educational program covers screening tests that are important in the care of adolescents and young adults (AYAs) with sickle cell disease and the most commonly used medications in this patient group. It also covers reproductive health considerations AYAs with sickle cell disease, including the need for contraception, the existing knowledge gaps, and the epidemiology and management of priapism. Finally, the program addresses practical pain management strategies in AYAs with sickle cell disease.

• Emily Riehm Meier, MD, MSHS

March 19, 2019

5:00 PM, Eastern, March 15, 2020

The estimated time to complete this activity is 45 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better. Successful completion of the post-test is required to earn AAPA Category 1 CME credit. Successful completion is defined as a cumulative score of at least 70 percent correct.
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is provided for 0.75 contact hours under ANCC criteria.

---

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid for one year from 03/15/2019. PAs should only claim credit commensurate with the extent of their participation.

Contact Information

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

System Requirements

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

19CE072 - Best Transition Practices for Adolescents and Young Adults with Sickle Cell Disease

The purpose of this program is to enable the learner to increase knowledge of the care needs of adolescents and young adults (AYAs) by the emotional and social development of adolescence, the six core elements of a transition program, and the emotional/social milestones that should be addressed in a transition program for adolescents and young adults (AYAs) living with sickle cell disease (SCD).

• Review emotional and social development of adolescence
• Identify health risks associated with transition among adolescents and young adults (AYAs) living with sickle cell disease (SCD)
• Differentiate pediatric and adult models of sickle cell care
• Discuss the six core elements of a transition program
• Describe the medical, social, and educational milestones that should be addressed in a transition program for AYAs living with SCD

Nurses, nurse practitioners, physician assistants, and other health care providers who treat adolescents and young adults with sickle cell disease and wish to improve outcomes associated with the transition from pediatric to adult care for these patients.

This online learning activity is focused on improving health outcomes for adolescents and young adults (AYAs) with sickle cell disease by improving transition programs and services available for these individuals. The activity will review the emotional and social development of adolescence. It will also discuss the health risks associated with transition among AYAs living with SCD. The module differentiates the pediatric and adult models of care, and examines the six core elements of transition programs, as derived from www.GotTransition.org. Finally, the activity will address the medical, social, and educational milestones that should be addressed in transition programs for AYAs with SCD.

• Emily Riehm Meier, MD, MSHS

March 19, 2019

5:00 PM, Eastern, March 15, 2020

The estimated time to complete this activity is 45 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better. Successful completion of the post-test is required to earn AAPA Category 1 CME credit. Successful completion is defined as a cumulative score of at least 70 percent correct.
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity is provided for 0.75 contact hours under ANCC criteria.

---

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid for one year from 03/15/2019. PAs should only claim credit commensurate with the extent of their participation.

Contact Information

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

System Requirements

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.

18CE087 - An Overview of the Background, Inheritance, and Physiology of von Willebrand Disease

The purpose of this learning activity is to enable the learner to develop an understanding of von Willebrand disease (VWD) by providing information about the discovery and evolution of knowledge about VWD, the production and functions of von Willebrand factor (VWF), and the differentiation of the classifications of VWD

• Explain the history of von Willebrand Disease (VWD) including its discovery and evolution of scientific understanding of the disorder
• Examine the production and functions of von Willebrand factor (VWF)
• Differentiate among the multiple classifications for VWD, including type 1, type 2, and type 3

Nurses and other healthcare professionals employed within the federally recognized U.S. hemophilia treatment center network (USHTCN) seeking training on von Willebrand disease (VWD) relating to the history and evolution of our understanding of the condition; the production and functions of von Willebrand factor (VWF), and the differentiation of the multiple classifications of VWD.

This learning activity will provide an overview of the background, inheritance, and physiology of von Willebrand Disease including an explanation of how the disease was first discovered and the evolution of knowledge about it. Furthermore, the production and functions of von Willebrand factor will be examined as well as distinguishing between the different types of VWD.

• Roshni Kulkarni, MD
• Usha M Reddy, MD
• Bruce Evatt, MD
• Connie Miller, PhD

June 19, 2018

5:00 PM Eastern, June 19, 2019

The estimated time to complete this activity is 45 minutes. In order to receive contact hours, you must complete the following prior to the course expiration date:

• Read the Program Announcement Form
• Complete the learning activity
• Complete the evaluation
• Complete the post-test with a score of 70% or better
• Upon successful completion of the post-test your certificate of completion will be available to print or save

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity is provided for 0.75 contact hours under ANCC criteria.

If you have any questions about this activity, please contact Natalie Duncan in Indianapolis, IN, 317-871-0011 ext 273, toll-free 877-256-8837, or via email at nduncan@ihtc.org. For technical support please email support@partnersprn.org or open a ticket in the Partners Support Center.

• 2 gigabytes of RAM
• High speed internet connection
• Any one Internet browser:
  • Firefox (Most Current Version)
  • Safari (Most Current Version)
  • Google Chrome (Most Current Version)
  • MS Internet Explorer (Most Current Version)
  • Cookies and JavaScript must be enabled in all browsers.
  • All browsers must have flash plug in installed and enabled.
• Cookies and JavaScript must be enabled in all browsers.
• All browsers must have flash plug in installed and enabled.